MOUNTAIN VIEW, Calif .-- (BUSINESS WIRE) ---- anro #cns--Alto Neuroscience, Inc. ("Alto†) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, announced today that it has entered into a securities purchase agreement with institutional and accredited investors to sell securities in a private placement financing (the "PIPE†) for gross proceeds of approximately 50 million, before deducting offering expenses. The f ...